| None |
0 |
0 |
| Known MRSA patients (e.g., re-admitted) |
132 |
98.50% |
| Contact patients (patients who have been in contact with MRSA carriers, e.g., shared a room with them) |
127 |
94.80% |
| Risk patients (e.g., from rehabilitation clinics or care homes, hospitals, on dialysis, indwelling catheter, chronic wound/skin ulcer/gangrene/deep soft-tissue infection, burn injury, patients who have received antibiotics in the past 6 months, patients with devices, e.g. indwelling catheter, etc.) |
115 |
85.80% |
| All patients in one intensive care unit |
17 |
12.70% |
| All patients in all intensive care units |
15 |
11.20% |
| All patients in selected intensive care units |
26 |
19.40% |
| All patients on selected non-intensive care units |
6 |
4.50% |
| When do you screen to identify new MRSA patients (i.e., excluding monitoring nares cultures or control cultures for known MRSA patients)? (Multiple answers possible) |
| Not at all |
21 |
15.70% |
| At admission |
110 |
82.10% |
| At regular intervals, or other (e.g., weekly) |
19 |
14.20% |
| At discharge |
2 |
1.50% |
| Other mode (e.g., outpatient department, primary care physician) |
18 |
13.40% |
| What is screened at inpatient admission? (n = 134) |
| Nose only |
3 |
2.20% |
| Pharynx only |
0 |
0 |
| Wound if any |
3 |
2.20% |
| Nasopharynx |
2 |
1.50% |
| Nose and wound if any |
28 |
20.90% |
| Nasopharynx and wound if any |
48 |
35.80% |
| Nasopharynx and wound if any, plus additional cultures (e.g., forehead/scalp border, perineum, rectum) |
40 |
29.90% |
| No information |
10 |
7.50% |
| Does the screening use the PCR method (results within 2–5 hours)? (n = 134) |
| Yes |
48 |
35.80% |
| Do you have an alert system (flagging) to identify previously positive (known) patients at re-admission? (n = 134) |
| Yes |
97 |
72.40% |
